1. Home
  2. RLMD vs SEED Comparison

RLMD vs SEED Comparison

Compare RLMD & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • SEED
  • Stock Information
  • Founded
  • RLMD 2004
  • SEED 1997
  • Country
  • RLMD United States
  • SEED China
  • Employees
  • RLMD N/A
  • SEED N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • SEED Farming/Seeds/Milling
  • Sector
  • RLMD Health Care
  • SEED Consumer Staples
  • Exchange
  • RLMD Nasdaq
  • SEED Nasdaq
  • Market Cap
  • RLMD 11.5M
  • SEED 12.1M
  • IPO Year
  • RLMD N/A
  • SEED N/A
  • Fundamental
  • Price
  • RLMD $0.38
  • SEED $1.76
  • Analyst Decision
  • RLMD Hold
  • SEED
  • Analyst Count
  • RLMD 4
  • SEED 0
  • Target Price
  • RLMD $4.25
  • SEED N/A
  • AVG Volume (30 Days)
  • RLMD 881.7K
  • SEED 38.0K
  • Earning Date
  • RLMD 03-18-2025
  • SEED 02-19-2025
  • Dividend Yield
  • RLMD N/A
  • SEED N/A
  • EPS Growth
  • RLMD N/A
  • SEED N/A
  • EPS
  • RLMD N/A
  • SEED 1.21
  • Revenue
  • RLMD N/A
  • SEED $16,516,031.00
  • Revenue This Year
  • RLMD N/A
  • SEED N/A
  • Revenue Next Year
  • RLMD N/A
  • SEED N/A
  • P/E Ratio
  • RLMD N/A
  • SEED $1.57
  • Revenue Growth
  • RLMD N/A
  • SEED 64.93
  • 52 Week Low
  • RLMD $0.34
  • SEED $1.52
  • 52 Week High
  • RLMD $7.22
  • SEED $6.38
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 27.23
  • SEED 29.73
  • Support Level
  • RLMD $0.36
  • SEED $1.70
  • Resistance Level
  • RLMD $0.49
  • SEED $1.93
  • Average True Range (ATR)
  • RLMD 0.04
  • SEED 0.16
  • MACD
  • RLMD 0.07
  • SEED -0.01
  • Stochastic Oscillator
  • RLMD 12.64
  • SEED 22.04

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About SEED Origin Agritech Limited

Origin Agritech Ltd is a Chinese agricultural technology company. In crop seed biotechnologies, the company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.

Share on Social Networks: